Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver Transplantation

被引：1
|
作者：
Burgos, Maria Martinez [1 ]
Grande, Rocio Gonzalez [1 ]
Ortega, Susana Lopez [1 ]
Leiva, Inmaculada Santaella [1 ]
De La Cruz Lombardo, Jesus [1 ]
Santoyo, Julio Santoyo [2 ]
Perez, Miguel Jimenez [1 ]
机构：
[1] Reg Univ Hosp Malaga, Digest Syst Clin Management Unit, Malaga 29010, Spain
[2] Reg Univ Hosp Malaga, Hepatobiliary Surg Clin Management Unit, Malaga, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 2023年 / 55卷 / 01期
关键词：
D O I：
10.1016/j.transproceed.2022.12.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The treatment of hepatitis C virus (HCV) has been a revolution in hepatology. Since the begin-ning of transplantation, liver cirrhosis and hepatocarcinoma on HCV cirrhosis has been the main etiology of liver transplantation. We set out to analyze the impact that C virus treatment has had on liver transplantation. To do so, we divided our cohort into 2 periods, one before virus treat-ment (from 2000-2014) and one after the onset of treatment (2014-2020). Taling into account this differentiation, we analyzed the percentage of patients transplanted for hepatocarcinoma over cirrhotic liver by HCV in both groups. Among the patients transplanted for HCV, we ana-lyzed whether there were differences in hepatocarcinoma recurrences according to their serologic status at the time of transplantation.
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [41] Complications of HCV treatment after liver transplantation.
    Pawlowska, Joanna
    Teisseyre, Mikolaj
    Jankowska, Irena
    Kalicinski, Piotr
    Dzierzanowska-Fangrat, Katarzyna
    Kluge, Przeinyslaw
    Teisseyre, Joanna
    Socha, Jerzy
    Woynarowski, Marek
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 93 - 93
  • [42] Successful Continuation of HCV Treatment After Liver Transplantation
    Fernandez Carrillo, Carlos
    Crespo, Gonzalo
    de la Revilla, Juan
    Castells, Lluis
    Buti, Maria
    Luis Montero, Jose
    Fabrega, Emilio
    Fernandez, Inmaculada
    Serrano-Millan, Cristina
    Hernandez, Victoria
    Luis Calleja, Jose
    Londono, Maria-Carlota
    TRANSPLANTATION, 2017, 101 (05) : 1009 - 1012
  • [43] TREATMENT FOR RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION
    Guedes, Cassia
    Pousa, Fernanda
    Roma, Joyce
    Gonzalez, Ana Carolina
    Agolia, Luciana
    Enne, Marcelo
    Martinho, Jose Manoel
    Carius, Luciana
    Balbi, Elizabeth
    Pacheco-Moreira, Lucio
    LIVER TRANSPLANTATION, 2009, 15 (07) : S131 - S131
  • [44] DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods
    Ravaioli, F.
    Tame, M. R.
    Marasco, G.
    Vizioli, L.
    Morelli, M. C.
    Pinna, A. D.
    Conti, F.
    Andreone, P.
    Colecchia, A.
    Festi, D.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E39 - E39
  • [45] HCV GENOTYPES, POST TRANSPLANT HEPATITIS (PTH) AND HCV RECURRENCE AFTER LIVER-TRANSPLANTATION
    BELLI, LS
    SILINI, E
    ALBERTI, A
    BELLATI, G
    FESCE, E
    GELOSA, F
    ASTI, L
    RONDINARA, GF
    DECARLIS, L
    BELLI, L
    IDEO, G
    HEPATOLOGY, 1994, 20 (04) : A131 - A131
  • [46] TREATMENT OF HCV IN HCC PATIENTS AFTER LIVER TRANSPLANTATION IMPROVES SURVIVAL AND DECREASES RISK OF HCC RECURRENCE
    Niyazi, Fadi
    Sanghi, Vedha
    Abduljawad, Baraa
    Asfari, Mohammad Maysara
    Lopez, Rocio
    Menon, K. V. Narayanan
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2017, 152 (05) : S1103 - S1103
  • [47] A STATISTICAL MODEL TO STUDY COST-EFFECTIVENESS OF ANTIVIRAL TREATMENT IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION
    Logge, Christoph
    Vettorazzi, Eik
    Fischer, Lutz
    Nashan, Bjoern
    Sterneck, Martina
    HEPATOLOGY, 2009, 50 (04) : 553A - 553A
  • [48] Liver transplantation due to HCV - The problem of recurrence
    Patonai, A
    Nemes, B
    Sarvary, E
    Kobori, L
    Lengyel, G
    Weszelits, V
    Fehervari, I
    Perner, F
    Schaff, Z
    JOURNAL OF HEPATOLOGY, 2001, 34 : 35 - 35
  • [49] Sorafenib (Sor) and mTOR inhibitors (mTORinh) combination for hepatocarcinoma recurrence after liver transplantation.
    Garralda, E.
    Castroagudin, J. F.
    Bustamante, J.
    Salcedo, M.
    Sangro, B.
    Herrero, I.
    Testillano, M.
    Matilla, A.
    Cortes-Funes, H.
    Gomez-Martin, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Ganciclovir does not increase the risk of HCV recurrence after liver transplantation.
    Rabkin, JM
    Orloff, SL
    Corless, CL
    Brown, E
    Rosen, HR
    Olyaei, AJ
    TRANSPLANTATION, 2000, 69 (08) : S319 - S319
12345